| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-07 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.2 | 3e-06 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |